IOI-Loders Croklaan division Lipid Nutrition has strengthened its
position in the world CLA market with the acquisition of
PharmaNutrients' CLA One business.
PharmaNutrients has added another patent to its intellectual
property store, on the use of CLA One to prevent or minimize the
onset of stress catabolic response in patients who have undergone
surgery or suffer from auto-immune disorders...
US-based PharmaNutrients has developed a digylceride form of the
fatty acid CLA, which it says could offer enhanced fat loss through
an additional mechanism, reports Dominique Patton.
PharmaNutrients has taken further steps to build up its position in
the CLA market by filing the first structure-function claims for
the body composition benefits of its branded CLA (conjugated
linoleic acid) product CLA One.